<DOC>
	<DOCNO>NCT02287493</DOCNO>
	<brief_summary>In prospective , non-interventional , monocentric observational study pharmacokinetic property select antiinfective drug sustain low-efficiency dialysis ( SLED ) analyze . Plasma specimens quantify use high Performance liquid chromatography ( HPLC ) . Primary endpoint : Plasma level antiinfectives SLED Secondary endpoint : - 28-day-mortality - length stay intensive care unit ( ICU ) hospital - clinical microbiological cure infection Inclusion criterion : - age : &gt; 18 year - patient SLED - antiinfective treatment exclusion criterion : - miss informed consent</brief_summary>
	<brief_title>Pharmacokinetics Selected Antiinfectives During Sustained Low-efficiency Dialysis ( SLED )</brief_title>
	<detailed_description />
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>age : 18 old patient receive SLED either meropenem ceftazidim miss inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>